New hope for lymphoma patients: tailored treatment based on risk
NCT ID NCT06793189
First seen Apr 08, 2026 · Last updated May 15, 2026 · Updated 4 times
Summary
This study tests a personalized approach to treating marginal zone lymphoma, a slow-growing blood cancer. Researchers will assign treatments based on each patient's risk level, aiming to improve how long the cancer stays under control. About 145 newly diagnosed adults who need systemic therapy will participate, with the goal of finding more effective and safer options.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MARGINAL ZONE LYMPHOMA(MZL) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Affiliated First Hospital of China Medical University
RECRUITINGShenyang, Liaoning, China
Contact Email: •••••@•••••
-
Peking University Third Hospital
RECRUITINGBeijing, China
Contact Email: •••••@•••••
-
Shanghai Ruijin Hospital
RECRUITINGShanghai, China, 200025, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.